News about "Oncology"

Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025

Merck is set to showcase new data at ESMO 2025, highlighting advancements in oncology across emerging tumor types and early-stage diseases, with positive survival results from KEYNOTE-905 and KEYNOTE-B96 trials demonstrating the impact of KEYTRUDA (pembrolizumab) in bladder and ovarian cancers.

Oncology | 11/10/2025 | By Dineshwori |  442

Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas

Eli Lilly will invest USD 6.5 billion to set up a new API manufacturing facility in Houston, Texas—its eighth US site since 2020—creating over 4,600 jobs and boosting domestic production of small molecule medicines.

Oncology, | 24/09/2025 | By Dineshwori |  111

Johnson and Johnson Reports Over 18 Percent Jump in Q2 Earnings

Johnson and Johnson has reported its second-quarter 2025 results, with net earnings soaring 18.2 percent to USD 5.54 billion, up from USD 4.69 billion in the same period last year.

Oncology | 17/07/2025 | By Dineshwori |  196

Innovent's DOVBLERON Secures Second NMPA Approval for ROS1-Positive NSCLC

China's National Medical Products Administration (NMPA) has approved the second New Drug Application (NDA) of DOVBLERON®, a next-generation ROS1 tyrosine kinase inhibitor (TKI).

Oncology | 03/01/2025 | By Abha |  203

Flare Therapeutics Partners with Roche Accelerate Drug Discovery in Oncology

This partnership will leverage Flare Therapeutics' proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic compounds, to discover novel small molecule drugs aimed at previously undrugged transcription factor targets in oncology.

Oncology | 14/11/2024 | By Aishwarya |  440

Phanes PT217 Gets Orphan Drug Designation for Neuroendocrine Carcinoma

PT217 is a first-in-class bispecific antibody targeting delta-like ligand 3 (DLL3) and cluster of differentiation 47 (CD47) being developed for patients with NEC.

Oncology | 17/08/2024 | By Aishwarya |  288

Maiva Pharma Raises INR 1,000 Crore from Fundraising

Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).

Oncology | 03/05/2024 | By Aishwarya |  705

Sygnature Discovery Appoints New Chief Scientific Officer

Sygnature Discovery has appointed Dr. David Witty as Chief Scientific Officer (CSO) to its leadership team.

Oncology | 24/04/2024 | By Aishwarya |  752

Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201

Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety

Oncology | 26/03/2024 | By Manvi |  689

PCI Pharma to expand operations at Welsh site

The manufacturing operations will be upgraded as part of the company’s push into targeted oncology therapies

Oncology | 12/08/2022 | By Sudeep Soparkar |  842